comparemela.com

Latest Breaking News On - Interpace biosciences inc - Page 1 : comparemela.com

Next-Generation Sequencing: 2024 Report Highlights Clinical

Next-Generation Sequencing Market and Emerging Clinical Applications: NGS-Based diagnostics for 2020, 2021, 2022, 2023 and 2028

/PRNewswire/ The "Next-Generation Sequencing: Emerging Clinical Applications and Global Markets" report has been added to ResearchAndMarkets.com s offering..

France
Cambridge
Cambridgeshire
United-kingdom
Sweden
Beijing
China
Amoy
Fujian
Dublin
Ireland
San-francisco

Gene Expression Industry Analysis 2018-2023 & 2024-2033:

Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results

 ●Q3 Revenue of $9.1 million; an 11% increase year-over-year ●Q3 Test volume up 11% year-over-year ●Q3 Reimbursement improvement up 11% year-over-year, driven by additional commercial.

United-states
Chris-mccarthy
Interpace-bioscience
Tom-burnell
Interpace-biosciences
Company-medicare
Exchange-commission
Company-line-of-credit
Globenewswire-inc
Interpace-biosciences-inc
Novitas-solutions-inc
Securities-exchange

Form 8-K INTERPACE BIOSCIENCES, For: Nov 08

Form 8-K INTERPACE BIOSCIENCES, For: Nov 08
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Washington
Thomasw-burnell
Waterview-plaza
Interpace-biosciences-inc
Securities-exchange
Principal-executive-offices
Securities-act
Exchange-act
Securities-exchange-act
Interpace-biosciences
Current-report
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.